Skip to main content
    I

    IBEX Ltd (IBEX)

    Official site

    TECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NASDAQ

    $55.50
    -0.88 (-1.56%)

    Market Cap: $751.76M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    IBEX Ltd (IBEX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    IBEX has a market cap of $751.76M and an enterprise value of $716.72M. Its return on invested capital of 27.01% compares with a 2.60% median across 10 similar companies. Its trailing P/E of 16.3x is above its 5-year median of 10.6x.

    Total Valuation

    Enterprise value is 4.66% below the market cap, as cash exceeds debt.

    Market Cap$751.76M
    Enterprise Value$716.72M
    Latest price (Nov 17, 2026)$55.50

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count shrank 10.03% a year over 3 years.

    Shares Outstanding13.32M
    Shares Change (YoY)-0.32%
    Share Count Growth (3Y CAGR)-10.03%

    Valuation Ratios

    Sales and book value multiples are 1.1x and 4.1x. Its year-end P/E ranged from 9.0x to 15.2x from 2020 to 2025.

    P/E Ratio16.3x
    Forward P/E14.0x
    P/S Ratio1.1x
    Forward P/S1.0x
    P/B Ratio4.1x
    P/TBV Ratio4.4x
    P/FCF Ratio22.9x
    P/OCF Ratio12.6x
    PEG Ratio1.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 8.8x EBITDA and 21.8x free cash flow.

    EV / Earnings14.6x
    EV / Sales1.1x
    EV / EBITDA8.8x
    EV / EBIT12.0x
    EV / FCF21.8x

    Price Statistics

    The stock is up 54.90% over 52 weeks and trades 22.65% above its 50-day average.

    Beta (1Y)0.59
    52-Week Change+54.90%
    1-Month Change+21.47%
    3-Month Change+55.16%
    6-Month Change+78.57%
    5-Year Change+175.26%
    Total Return (1Y)+54.90%
    Total Return (3Y CAGR)+45.37%
    Total Return (5Y CAGR)+24.97%
    Return vs SPY (1Y)+45.51%
    Max Drawdown (1Y)-32.72%
    Max Drawdown (3Y)-37.14%
    Sharpe Ratio (1Y)1.15
    Correlation with SPY (1Y)0.21
    50-Day Average$45.25
    200-Day Average$34.99
    52-Week Range$25.94 to $57.92
    RSI (14 Days)73.0
    Average Volume (20 Days)154.26K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.03x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio2.03x
    Quick Ratio2.03x
    Debt / Equity0.01x
    Debt / EBITDA0.02x
    Debt / FCF0.05x
    Interest Coverage64.88x

    Returns and Efficiency

    Return on invested capital is 27.01% over the last 12 months, against a 5-year average of 22.22%.

    Return on Equity (ROE)27.03%
    Return on Assets (ROA)14.75%
    Return on Invested Capital (ROIC)27.01%
    Return on Capital Employed (ROCE)25.27%
    ROE (5Y Average)22.99%
    ROA (5Y Average)11.60%
    ROIC (5Y Average)22.22%
    Asset Turnover2.17x
    Receivables Turnover5.11x

    Taxes

    Income tax took 16.90% of pretax income over the last 12 months.

    Income Tax (TTM)$9.98M
    Effective Tax Rate16.90%

    Scores

    IBEX has an Altman Z-Score of 6.26, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score6.26
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $668.12M over the last 12 months is up 15.25% from the 12 months before.

    Revenue$668.12M
    Revenue Growth (YoY)+15.25%
    Gross Profit$668.12M
    Operating Income$59.56M
    Pretax Income$59.05M
    Net Income$49.07M
    EBITDA$79.97M
    EBIT$59.56M
    Reported EPS (TTM)$3.40

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 54.59% of the $332.56M in total assets.

    Cash and Equivalents$36.70M
    Total Debt$1.65M
    Net Cash$35.04M
    Net Cash Per Share$2.63
    Working Capital$99.63M
    Shareholder Equity$181.55M
    Book Value Per Share$13.63
    Tangible Book Value$169.72M
    Tangible Book Per Share$12.74
    Total Assets$332.56M
    Total Liabilities$151.01M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $27.33M of capital spending, operating cash flow left $32.32M of free cash flow.

    Operating Cash Flow$59.66M
    Capital Expenditures$27.33M
    Free Cash Flow$32.32M
    FCF Per Share$2.42
    Depreciation and Amortization$20.41M
    Share Repurchases$16.10M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 8.91%, against a 5-year average of 7.31%.

    Gross Margin100.00%
    Operating Margin8.91%
    Pretax Margin8.84%
    Net Margin7.34%
    EBITDA Margin11.97%
    EBIT Margin8.91%
    FCF Margin4.84%
    Gross Margin (5Y Average)71.64%
    Operating Margin (5Y Average)7.31%
    Net Margin (5Y Average)6.16%

    Growth

    Revenue grew 7.18% a year over 3 years, and EPS 21.24% a year.

    Revenue Growth (3Y CAGR)+7.18%
    Revenue Growth (5Y CAGR)+7.75%
    EPS Growth (3Y CAGR)+21.24%
    EPS Growth (5Y CAGR)+21.22%
    FCF Growth (3Y CAGR)+10.84%
    Operating Income Growth (3Y CAGR)+10.74%

    Revenue and profit by year

    Dividends and Yields

    IBEX does not pay a dividend. Its free cash flow yield is 4.37%.

    Earnings Yield6.13%
    FCF Yield4.37%
    Buyback Yield2.18%
    Shareholder Yield2.18%

    Peer Position

    Against 8 similar companies, IBEX has the 5th highest P/E.

    P/E Ratio16.3x vs 15.5x median
    P/S Ratio1.1x vs 1.5x median
    ROIC27.01% vs 2.60% median
    Revenue Growth (Trailing 4 Quarters, YoY)+15.25% vs +6.59% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 10.07% and EPS growth at 14.34% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+10.07%
    EPS Growth Forecast (2Y CAGR)+14.34%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IBEX

    What is IBEX's market cap?

    IBEX has a market cap of $751.76M. Its enterprise value, which adds debt and subtracts cash, is $716.72M.

    What is IBEX's P/E ratio?

    IBEX has a trailing P/E ratio of 16.3x and a forward P/E of 14.0x.

    How many shares of IBEX are outstanding?

    IBEX has 13.32M shares outstanding. The count is down 0.32% from a year earlier.

    Does IBEX pay a dividend?

    No. IBEX does not pay a dividend.

    How much debt does IBEX have?

    IBEX has $1.65M of total debt and $36.70M of cash and equivalents, a net cash position of $35.04M.